SIMPLEX QUANTUM Co., Ltd. Raised funds in series A round through third-party allotment

SIMPLEX QUANTUM Inc.
Raised funds in series A round through third-party allotment
SIMPLEX QUANTUM Co., Ltd. (Headquarters: Shibuya-ku, Tokyo;
Representative: Ryu Saito) has recently acquired Simplex Holdings Co., Ltd. (Headquarters: Minato-ku, Tokyo; Representative: Hideki Kaneko) and ITOCHU Technology Ventures Co., Ltd. A total of 550 million yen from Technology Ventures No. 5 Investment Business Limited Liability Union (Headquarters: Minato-ku, Tokyo; Representative: Shinzo Nakano) and ITOCHU Corporation (Headquarters: Minato-ku, Tokyo;
Representative: Keita Ishii) We raised funds.
*Funds were raised in the series A round from the above three companies. Purpose of fundraising
With the heart failure detection AI being used in hospitals, clinical trials associated with medical device approval procedures, medical device approval application to the Ministry of Health, Labor and Welfare, and US FDA approval costs.
Development cost for commercialization of heart failure detection AI as a service

Investor comment
■ Simplex Holdings Co., Ltd. President Hideki Kaneko
[Image 1d17238-24-0db5315d3e8be9a9a653-0.png&s3=17238-24-40f54d7a4e0225f33ab7b3bdaeaf7f7a-824x387.png
One of the AI ​​modules that SIMPLEX QUANTUM has developed so far, “heart failure/arrhythmia detection AI,” has been highly evaluated for its potential as a project that transcends the boundaries between industry, academia, and the public and private sectors. I’m getting We expect that the company’s technology and track record will demonstrate high synergies in expanding business into non-financial areas, which the Simplex Group is focusing on. In addition, we would like to use this investment as an opportunity to deepen our cooperation and explore ways to develop businesses that make the most of each other’s strengths.
■ ITOCHU Technology Ventures Co., Ltd. Executive Vice President Mr. Takeshi Abe [Image 2d17238-24-9d542b274c42ce3c83c2-4.png&s3=17238-24-70b213e28cfc65e64e5289587d91791d-3900x2925.png
The heart failure and arrhythmia detection AI developed and provided by SIMPLEX QUANTUM is based on advanced analysis technology that combines the knowledge of medical experts and IT specialists. Acquisition of large amounts of data and verification in clinical settings are also important factors, and we expect SIMPLEX QUANTUM, which has a network in the medical industry, to be able to achieve this. We would like to provide maximum support so that SIMPLEX QUANTUM can make a big leap forward as a player that will change the medical industry.
Mr. Hiroshi Kajiwara, Executive Officer, ITOCHU Corporation
[Image 3d17238-24-aeb5618245b8f7909a08-2.jpg&s3=17238-24-8610554a97d1d1b8cd756c28f04f43a3-354x146.jpg
Heart failure detection AI developed by SIMPLEX QUANTUM is a cutting-edge AI technology that detects heart failure from
electrocardiogram data. In addition, the AI ​​is expected to reduce the burden on medical personnel and medical expenses by encouraging heart failure patients to visit hospitals and receive treatment earlier. Through this capital tie-up, ITOCHU Corporation will support SIMPLEX QUANTUM’s business expansion, including the domestic and global development of the heart failure detection AI business, by maximizing the ITOCHU Group’s network.
【Company Profile】
SIMPLEX QUANTUM Inc.
Representative: Representative Director Ryu Saito
Established: October 3, 2014
Location: Shibuya CH Building 3F, 29-1 Sakuragaoka, Shibuya-ku, Tokyo Site: https://simplex-q.com
Inquiries regarding this matter: pr@simplex-q.com
Details about this release:
https://prtimes.jp/main/html/rd/p/000000024.000017238.html

MAIL:cr@prtimes.co.jp

rehow

Leave a Reply

Your email address will not be published.

%d bloggers like this: